DNA X amends 8-K to update disclosure on Series B preferred stock sale for $2.5 million

Reuters2026/08/13 20:02

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

DNA X filed an amended 8-K to update its disclosure under Item 3.02 on unregistered equity sales.
It reported selling the remaining 416,667 shares of Series B Preferred Stock on Aug. 7 for cash proceeds of $2.5 million.
Pro forma stockholders’ equity was estimated at $5.84 million as of Aug. 7, above Nasdaq’s $2.5 million continued-listing requirement.
The company is awaiting Nasdaq’s formal determination that it has regained compliance with the stockholders’ equity rule.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-037733), on August 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

DNA X amends 8-K to update disclosure on Series B preferred stock sale for $2.5 million

You may also like

Crypto prices